The reported evidence regarding non-Hodgkin lymphoma in general suggests that in cases of childhood NHL, and in cases where fertility preservation is desired, current chemotherapeutic regimens are safe and can spare fertility, particularly when GnRH agonists are used in conjunction with treatment. This evidence concerns the gene GNRH1 and non-Hodgkin lymphoma.